Cyprotex Highlights - July 2022
Join us in Copenhagen on 7th September 2022 for our complimentary workshop: ADME-Tox Strategies to Accelerate Drug Discovery. There will be the opportunity to network, and a buffet lunch and refreshments will be served throughout the day.
Speakers include:
- Anders Sonesson PhD, Ferring Pharmaeuticals: ADME Strategies for Peptide Drugs
- Paul Walker PhD, Cyprotex Discovery Ltd: The Use of Toxicogenomics in Early Pre-clinical Safety Assessment
- Janne Koch PhD, LEO Pharma A/S: LEO Pharma Early Toxicology Strategy
- Phil Butler PhD, Cyprotex Discovery Ltd: From Small Molecules to New Modalities – The Changing Landscape of ADME Screening
On 22nd September 2022, join Cyprotex at DoubleTree by Hilton San Francisco Airport to learn more about:
- designing ADME-Tox screening strategies
- planning, implementing and interpreting in vitro Drug-Drug Interaction studies
- new technologies for improving efficiency and IVIVE extrapolation in ADME-Tox
Enjoy our latest webinar now available to watch on demand: Using Relative Induction Score to Improve Risk Assessment of Clinical CYP3A4 Induction.
Join our in-house expert, Katie Plant, as she presents the most recent updates in CYP induction, including an overview of the recommended approach to assess CYP induction in vitro.
Read the latest news from parent company, Evotec:
- Evotec joins Boehringer Ingelheim and bioMérieux to create next generation of antimicrobials
- Evotec completes acquisition of Rigenerand Srl
- Academic collaboration with Bristol Myers Squibb selected for further development
Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:
.jpeg)
Telephone:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683
Email:
enquiries@cyprotex.com